Supraorbital Basosquamous Carcinoma Treated with Cemiplimab Followed by Sonidegib: A Case Report and Review of the Literature

<i>Basal cell carcinoma</i> (BCC) is a skin cancer with low local aggressiveness and a low tendency to metastasize. <i>Basosquamous Carcinoma</i> (BSC) represents an aggressive histological subtype of BCC with intermediate features between <i>Squamous Cell Carcinoma</i> (SCC) and BCC. Cemiplimab is...

Полное описание

Библиографические подробности

Главные авторы:	Ilaria Proietti, Luca Filippi, Ersilia Tolino, Nicoletta Bernardini, Francesca Svara, Federica Trovato, Claudio Di Cristofano, Vincenzo Petrozza, Oreste Bagni, Andrea Vizzaccaro, Nevena Skroza, Concetta Potenza
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2023-10-01
Серии:	Biomedicines
Предметы:	<i>Basal cell carcinoma</i> basosquamous carcinoma <i>Squamous Cell Carcinoma</i> immunotherapy Cemiplimab hedgehog inhibitors
Online-ссылка:	https://www.mdpi.com/2227-9059/11/11/2903
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!